News

If you struggle with knee pain, this new treatment may sound like music to your ears. Researchers have found a way to ease ...
NeuroPace NPCE recently announced promising preliminary one-year results from its pivotal NAUTILUS trial, evaluating the RNS ...
NeuroPace announced preliminary one-year results from its clinical study evaluating neuromodulation therapy for generalized ...
NeuroPace's RNS System trial showed a strong safety profile and subgroup efficacy in drug-resistant epilepsy, prompting FDA ...
NeuroPace Inc. (NASDAQ:NPCE) saw its stock nosedive by 36.1% today after announcing that its NAUTILUS clinical trial failed ...
A new study published in Molecular Psychiatry provides preliminary evidence that cannabidiol, a compound derived from ...
LONDON, GREATER LONDON, UNITED KINGDOM, May 26, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...
Researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s ...
A new study from researchers at Wake Forest University School of Medicine shows an improvement in screening rates for anxiety ...
A new study from researchers at Wake Forest University School of Medicine shows an improvement in screening rates for anxiety ...
Scientists say they've put together a molecular toolkit that could be used to treat a variety of brain diseases, possibly ...
Up to 40% of all epilepsy diagnoses in the United States are of the drug-resistant variety, affecting 1.2 million people ...